AG27464
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1g | in stock | $10.00 | $7.00 | - + | ||
5g | in stock | $33.00 | $23.00 | - + | ||
10g | in stock | $61.00 | $43.00 | - + | ||
25g | in stock | $97.00 | $68.00 | - + | ||
100g | in stock | $297.00 | $208.00 | - + | ||
500g | in stock | $1,317.00 | $922.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AG27464 |
Chemical Name: | Chelidamic acid |
CAS Number: | 499-51-4 |
Molecular Formula: | C7H5NO5 |
Molecular Weight: | 183.1183 |
MDL Number: | MFCD31536703 |
SMILES: | Oc1cc(nc(c1)C(=O)O)C(=O)O |
NSC Number: | 3983 |
Complexity: | 320 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 3 |
Rotatable Bond Count: | 2 |
XLogP3: | -0.4 |
4-Hydroxypyridine-2,6-dicarboxylic acid (HPDCA) plays a crucial role in chemical synthesis as a versatile building block. This compound is widely used in the pharmaceutical and agrochemical industries as a key intermediate in the synthesis of various active compounds. In the realm of drug discovery, HPDCA serves as a precursor for the synthesis of potential drug candidates, contributing to the development of novel medications. Its unique structure and reactivity make it an indispensable tool in the creation of complex molecules with specific biological activities. Additionally, HPDCA can be utilized in the preparation of ligands for coordination chemistry and metal-organic frameworks, showcasing its versatility in a wide range of synthetic applications.
Acta crystallographica. Section C, Crystal structure communications 20120901
Acta crystallographica. Section E, Structure reports online 20120301
Dalton transactions (Cambridge, England : 2003) 20120221
Acta crystallographica. Section E, Structure reports online 20120101
Acta crystallographica. Section E, Structure reports online 20120101
Acta crystallographica. Section E, Structure reports online 20110701
Acta crystallographica. Section E, Structure reports online 20110601
Acta crystallographica. Section E, Structure reports online 20110401
Acta crystallographica. Section E, Structure reports online 20110301
Dalton transactions (Cambridge, England : 2003) 20110128
Acta crystallographica. Section E, Structure reports online 20101201
Acta crystallographica. Section E, Structure reports online 20101101
Acta crystallographica. Section E, Structure reports online 20100901
Acta crystallographica. Section E, Structure reports online 20100401
BMC bioinformatics 20100101
Inorganic chemistry 20091207
Acta crystallographica. Section E, Structure reports online 20091101
Acta crystallographica. Section E, Structure reports online 20090701
Chirality 20090501
Dalton transactions (Cambridge, England : 2003) 20090407
Dalton transactions (Cambridge, England : 2003) 20090307
Acta crystallographica. Section E, Structure reports online 20081201
Acta crystallographica. Section E, Structure reports online 20081001
Acta crystallographica. Section E, Structure reports online 20081001
Acta crystallographica. Section E, Structure reports online 20080901
Acta crystallographica. Section E, Structure reports online 20080901
Acta crystallographica. Section E, Structure reports online 20080801
Acta crystallographica. Section E, Structure reports online 20080301
Bioorganic & medicinal chemistry letters 20080115
Bioorganic & medicinal chemistry letters 20080115
Acta crystallographica. Section E, Structure reports online 20080101
Acta crystallographica. Section E, Structure reports online 20080101
The journal of physical chemistry. B 20061019
Inorganic chemistry 20060724
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Chemistry (Weinheim an der Bergstrasse, Germany) 20051216
Journal of inorganic biochemistry 20030501
The Journal of biological chemistry 20020419